Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Affirm Stock Is a Wait and See Until August 9’s Quarterly Results

AFRM stock will build on its business momentum from here after the company posted strong transaction volumes and merchandise volume growth.

7 Tech Stocks to Buy on Any Dips

Tech stocks to buy with temporary stock price dip create great buying opportunities for the long-term investors willing to hold for years.

Should Investors Buy SoFi After its Q1 Earnings Report?

Sofi reported strong member growth and product sales in its earnings report. Data that supports its business momentum is still solid.

FuboTV Stock Cratered, But It Is Still a Buy

Short-sellers have a concentrated bet against FuboTV even though the stock already lost most of its value from its 52-week high.

AMC Stock: Why it’s Time to Bail Right Now

AMC stock relied almost entirely on memes or momentum trading, and once gone, fundamentals will determine its share price.

7 Warren Buffett Stocks to Buy After Berkshire’s Annual Meeting

The energy hedge from Occidental is most compelling for Buffett fans, followed by companies buying back shares aggressively.

7 Retirement Stocks for Steady Long-Term Income Growth

Investors looking for retirement stocks should look for companies with high growth and steady income and shun risky, unproven stocks.

Avoid UiPath Stock Until It Gets Back on the Right Trail

Nasdaq’s bear market is pummeling UiPath’s stock performance that investors should consider Microsoft or the index instead.

Wait Until June before Buying Snowflake Stock

Snowflake is entrenching itself at the center of digital transformation in industries like retail and government.

7 Sold-Off Stocks Ready to Surge From Here

These stocks fell enough after investors gave up, creating a tremendous buying chance for patient investors.